Most of the gliomas categorized in the “SOX10 promoter hypomethylation” group consisted of DCGs, thalamic and brainstem gliomas in the “K27” group, and some of the cerebral gliomas in the “RTK I” group. This evidence concerns the gene SOX10 and central nervous system cancer.